2007
DOI: 10.1002/jso.20947
|View full text |Cite
|
Sign up to set email alerts
|

Use of PET probe in surgical oncology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Not only the gamma-emitting pharmaceuticals, but also positron-emitting pharmaceuticals such as 18 F-FDG have been used for RGS, referred to as FDG-guided or FDG-directed surgery (Cohn et al 2008, Povoski et al 2008, Molina et al 2009, Kim et al 2011, James and Gambhir 2012. In the most common types of malignant tumor, FDG accumulate in tumor cell is increased with their malignancy.…”
Section: Introductionmentioning
confidence: 99%
“…Not only the gamma-emitting pharmaceuticals, but also positron-emitting pharmaceuticals such as 18 F-FDG have been used for RGS, referred to as FDG-guided or FDG-directed surgery (Cohn et al 2008, Povoski et al 2008, Molina et al 2009, Kim et al 2011, James and Gambhir 2012. In the most common types of malignant tumor, FDG accumulate in tumor cell is increased with their malignancy.…”
Section: Introductionmentioning
confidence: 99%